Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Biomerica, Inc. (BMRA) had Stock-Based Compensation of $0.46M for the most recently reported fiscal quarter, ending 2025-05-31.
| Income Statement Financials | |
$0.75M |
|
$-1.54M |
|
$1.00M |
|
$-0.25M |
|
$2.31M |
|
$-1.57M |
|
$0.03M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.57M |
|
$-1.46M |
|
2.30M |
|
2.30M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$4.88M |
|
$0.14M |
|
$1.07M |
|
$5.95M |
|
$1.74M |
|
-- |
|
$0.10M |
|
$1.84M |
|
$4.11M |
|
$3.88M |
|
$4.11M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-3.84M |
|
$-0.04M |
|
$2.11M |
|
$4.17M |
|
$2.40M |
|
$-1.77M |
|
|
Stock-Based Compensation |
$0.46M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.98% |
|
-209.08% |
|
-209.08% |
|
-- |
|
-205.61% |
|
-206.14% |
|
$-3.84M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.67 |
|
1.02 |
|
87.84 |
|
-37.61% |
|
-39.82% |
|
-25.97% |
|
-37.61% |
|
$1.61 |
|
$-1.67 |
|
$-1.67 |
|